Toxins
Abcam Streptozocin, Pancreatic beta-cell to x in, 500MG
MW 265.22 Da, Purity >95%. Selective pancreatic β-cell toxin. DNA alkylating agent. Diabetagen and anticancer activity in vivo.
The product is subject to the following: Abcam Restricted Use Statement
Cayman Chemical Anti-Cholera Toxin B Subunit
A natural amino alcohol that serves as an intermediate in the biosynthesis of the amino acid L-histidine in bacteria archaebacteria fungi and plants
Cayman Chemical Cholera ToxInazIde free 1mg
A multimeric enterotoxin that catalyzes the ADP-ribosylation of the Gsα protein, which activates adenylate cyclase and increases the intracellular concentration of cAMP; causes the hypersecretion of chloride and bicarbonate ions, which results in increased fluid secretion and the severe diarrhea characteristic of the disease, cholera
Cayman Chemical 16-epI LatrunculIn B 100ug
A naturally derived macrolide that inhibits actin polymerization in vitro at 5-10 UG/ml; demonstrates cytotoxic activity in mouse KA31T and NIH3T3 tumor cells (GI50s = 1 and 4 UG/ml, respectively) and antiviral activity against HSV-1 (ED50 = 1 UG/ml)
Medchemexpress LLC HY-13629 200mg Medchemexpress, Etoposide CAS:33419-42-0 Purity:>98%
Medchemexpress, HY-13629 200mg Etoposide CAS:33419-42-0 Etoposide (VP-16; VP-16-213) is an anti-cancer chemotherapy agent. Etoposide inhibits topoisomerase II, thus stopping DNA replication. Etoposide induces cell cycle arrest, apoptosis and autophagy. Purity:>98% Medchemexpress has over 10000 novel life-science reagents, reference compounds, APIs and natural compounds for laboratory and scientific use. Other quantity can also be offered.
Medchemexpress LLC Mevastatin | 73573-88-3 | 99.5% | 390.51 | 500 MG
Mevastatin (Compactin) is the first HMG-CoA reductase inhibitor belonging to the statins class. It acts as a lipid-lowering agent, induces apoptosis, and arrests cancer cells in the G0/G1 phase. Mevastatin also enhances endothelial nitric oxide synthase (eNOS) mRNA and protein levels. It exhibits antitumor activity and holds potential for treating cardiovascular diseases.
- First HMG-CoA reductase inhibitor
- Belongs to the statins class
- Lipid-lowering agent
- Induces apoptosis
- Arrests cancer cells in G0/G1 phase
- Increases endothelial nitric oxide synthase (eNOS) mRNA and protein levels
- Exhibits antitumor activity
- Potential for cardiovascular diseases treatment